Darifenacin HBr

CAS No. 133099-07-7

Darifenacin HBr( UK 88525-04 )

Catalog No. M11319 CAS No. 133099-07-7

Darifenacin is a selective muscarinic receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 29 In Stock
50MG 39 In Stock
100MG 47 In Stock
200MG Get Quote In Stock
500MG 105 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Darifenacin HBr
  • Note
    Research use only, not for human use.
  • Brief Description
    Darifenacin is a selective muscarinic receptor antagonist.
  • Description
    Darifenacin is a selective muscarinic receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UK 88525-04
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    M3 mAChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    133099-07-7
  • Formula Weight
    505.45
  • Molecular Formula
    C28H31BrN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 117 mg/mL (230.56 mM)
  • SMILES
    C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Moriya H, et al. Life Sci. 1999; 64(25):2351-8.
molnova catalog
related products
  • Eleutheroside E

    Eleutheroside E has anti-inflammatory effects by inhibiting NF-κB activities.

  • Aclidinium bromide

    Aclidinium Bromide inhibits human muscarinic AChR M1, M2, M3, M4 and M5 with Ki of 0.1 nM, 0.14 nM, 0.14 nM, 0.21 nM and 0.16 nM, respectively.

  • Cladribine

    Cladribine is an adenosine deaminase inhibitor used to treat hairy cell leukemia and multiple sclerosis.